The Procter & Gamble Company (NYSE:PG) Shares Sold by Quotient Wealth Partners LLC

Quotient Wealth Partners LLC decreased its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 7.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,307 shares of the company’s stock after selling 1,288 shares during the quarter. Quotient Wealth Partners LLC’s holdings in Procter & Gamble were worth $2,651,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble in the second quarter valued at about $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble during the 2nd quarter valued at $29,000. Ruedi Wealth Management Inc. grew its stake in Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC bought a new stake in Procter & Gamble in the second quarter valued at about $34,000. Finally, Transcendent Capital Group LLC bought a new position in Procter & Gamble during the fourth quarter worth $31,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock worth $65,140,718 over the last ninety days. 0.17% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

PG has been the topic of several analyst reports. DA Davidson assumed coverage on Procter & Gamble in a research report on Wednesday. They issued a “neutral” rating and a $159.00 target price on the stock. Evercore ISI increased their target price on shares of Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. JPMorgan Chase & Co. upped their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Finally, StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Ten equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $175.05.

Check Out Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Trading Down 0.4 %

NYSE:PG traded down $0.67 during mid-day trading on Thursday, hitting $168.60. The company had a trading volume of 1,350,032 shares, compared to its average volume of 6,656,731. The firm has a market cap of $397.92 billion, a P/E ratio of 27.54, a P/E/G ratio of 3.73 and a beta of 0.41. The Procter & Gamble Company has a fifty-two week low of $141.66 and a fifty-two week high of $177.94. The business’s fifty day moving average is $171.39 and its two-hundred day moving average is $166.65. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The firm had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business’s revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.37 earnings per share. As a group, research analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.39%. Procter & Gamble’s payout ratio is 65.69%.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.